Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Three Batches Consistency and Immunity Duration of the Post-marketing Inactivated Enterovirus Type 71 (EV71) Vaccine in Children Aged 6-71 Months

NCT02889497 is registered in ClinicalTrials.gov with Beijing Chaoyang District Centre for Disease Control and Prevention as lead sponsor.

NCT NCT02889497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02889497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Three Batches Consistency and Immunity Duration of the Post-marketing Inactivated Enterovirus Type 71 (EV71) Vaccine in Children Aged 6-71 Months
Lead sponsor
Beijing Chaoyang District Centre for Disease Control and Prevention
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2016
Completion date
September 30, 2019
Enrollment
20,900 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hand foot and mouth disease